Enliven Therapeutics Archives - Catalyst Daily

Enliven Therapeutics, Inc. ($ELVN) Initiates Underwritten Common Stock Sale

NewsDesk CD - June 13, 2025 6:21 am

Catalyst News

Ormat Technologies ($ORA) Secures Full Ownership of 20MW Blue Mountain Facility

Staff Writer - June 18, 2025 8:41 am

Guild Holdings Company ($GHLD) shareholders to receive $20 per share, a 56% premium

NewsDesk CD - June 18, 2025 8:30 am

LiveOne ($LVO) Reports 37.5% Revenue Drop Year-Over-Year in Q4

Catalyst Desk - June 18, 2025 8:02 am

Aurora Cannabis ($ACB) Posts Strong Q4 Revenue, Narrowing Loss Per Share

NewsDesk CD - June 18, 2025 7:00 am

Korn Ferry ($KFY) Beats Q4 Earnings Expectations with $1.32 per Share

NewsDesk CD - June 18, 2025 6:49 am

ARRAY Technologies (ARRY) Boosts Growth with APA Solar Acquisition

NewsDesk CD - June 18, 2025 6:30 am

GMS ($GMS) Posts Adjusted EPS of $1.29, Surpassing $1.11 Estimate in Q4 2025

Staff Writer - June 18, 2025 6:08 am

MakeMyTrip Ltd ($MMYT) Raises Public Offering from 14M to 16M Shares

Catalyst Desk - June 18, 2025 6:02 am

Ryde Group Ltd ($RYDE) Advances Clean Mobility with Atoll Acquisition

Staff Writer - June 18, 2025 6:00 am

Sonoma Pharmaceuticals ($SNOA) Reports $3.75M Q4 Revenue, Below Forecast

Staff Writer - June 17, 2025 5:00 pm